Biomerica Inc

biomerica.com

What Do They Do?

Sells diagnostic test kits for clinical laboratories, including tests for diseases, food intolerances and other conditions, plus rapid tests for home use and physicians’ offices. Provides development and manufacturing services for third-party diagnostic products.

How Do They Make Money?

Clinical-lab and other diagnostic product sales bring in money when products ship. Contract manufacturing customers are billed when services are performed, with some projects billed as the work progresses.

revenue

Segment	Share	How money arrives
Clinical Lab Sold outright	61% FY2023: 62%	Sold outright
Contract Manufacturing Sold outright	20% FY2023: 11%	Sold outright
Over-The-Counter Sold outright	18% FY2023: 22%	Sold outright
Physicians office Sold outright	0.2% FY2023: 4.7%	Sold outright

Who Are Their Customers?

Hospitals, clinical laboratories, research institutions and pharmaceutical companies are served through distributors. Over-the-counter products are sold to drugstores and online customers directly or through distributors; physicians’ office products go to physicians and distributors.

Customers above 10% of revenue, FY2026

of revenue from one customer

FY2025: 31% from one customer

Do Revenues Turn Into Profits?

No. It lost $3.8M in FY2026.

Operating income, FY2026

−119% of revenue

▲ +4% (Loss) vs FY2025 (−$5.1M, −97%)

Net income, FY2026

−85% of revenue

▼ −24% (Loss) vs FY2025 (−$5M, −94%)

How Are They Changing?

Since the FY2026 annual report

Latest quarter: Q1 FY2027, the three months to Aug 31, 2026

Revenue: ▼ −8%; vs $1.4M in Q1 FY2026
Net income: ▼ Now a loss; vs $2K in Q1 FY2026

Clinical Lab share of total vs 74.2% in Q1 FY2026

Shrinking. Revenue fell 76% in 4 years, from $18.9M in FY2022 to $4.5M in FY2026, about 30% a year.

inFoods IBS reimbursement The older report described inFoods IBS as a cash-pay laboratory test while reimbursement was being pursued. The latest report cites a Medicare payment rate and initial claims paid, alongside physician marketing efforts.

hp+detect sales The older report said the H. pylori test was awaiting FDA clearance; the latest says hp+detect received clearance and a European clinical laboratory chain ordered it.

Revenue over time

Clinical Lab Contract Manufacturing Over-The-Counter Physicians office

$20M$10M$0

FY2022 FY2023 FY2024 FY2025 FY2026

Comments